Clinical Trial Update: A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the effect of a low-fat meal and evening dosing on exposure to KAI-7535 in adults with obesity or overweight; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• KAI-7535

Snippet

Sponsor: Kailera | Conditions: Obesity, Overweight | Phase 1 | Status: COMPLETED